M
Monopar Therapeutics D
D
MNPR
32.250
USD
-1.40
(-4.16%)
مفتوح الان
حجم التداول
421
الربح لكل سهم
-2
العائد الربحي
-
P/E
-8
حجم السوق
197,215,652
العنوان: Monopar Therapeutics Inc
القطاع: Healthcare
الصناعة: Biotechnology
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.